CD1 mice received repeated PRO (16 mg/kg intraperitoneally) or vehicle (cyclodextrin) for 36 hours after TBI. Sham animals underwent craniotomy without TBI. The modified Neurological Severity Score graded neurologic recovery. A second craniotomy allowed in聽vivo observation of pial EC/PMN interactions and vascular macromolecule leakage. Wet/dry ratios assessed cerebral edema.
Compared with the vehicle, PRO reduced subjective cerebral swelling (2.9 卤 .1 vs 1.2 卤 .1, P < .001), PMN rolling (95 卤 1.8 vs 57 卤 2.0 cells/100 渭m/min, P < .001), total EC/PMN adhesion (2.0 卤 .4 vs .8 卤 .1 PMN/100 渭m, P < .01), and vascular permeability (51.8% 卤 4.9% vs 27.1% 卤 4.6%, P < .01). TBI groups had similar a Neurological Severity Score and cerebral wet/dry ratios (P > .05).
PRO reduces live pericontusional EC/PMN and BBB macromolecular leakage after TBI. Direct PRO effects on the microcirculation warrant further investigation.